-
Your RFQ cart is empty!
Ertapenem
Venkatasai is a leading provider of pharmaceutical reference standards, specializing in the supply of high-purity Ertapenem reference materials. Our portfolio includes both pharmacopeial and non-pharmacopeial impurities, metabolites, stable isotope-labeled compounds, and nitrosamine derivatives (N-NO products). These reference standards play a crucial role in pharmaceutical R&D, aiding in formulation development, ANDA/DMF submissions, quality control, method validation, stability studies, and impurity profiling—including the identification and assessment of potentially genotoxic impurities.
Each Ertapenem-related product is rigorously characterized and delivered with a detailed Certificate of Analysis (COA) and comprehensive analytical data to ensure regulatory compliance. Upon request, we also offer EP/USP traceable standards. To maintain the highest quality standards, all materials are subject to periodic re-testing and continuous quality monitoring.
Ertapenem is a medication used to manage high blood pressure and chest pain. It acts as both an alpha- and beta-adrenergic receptor blocker, making it effective for treating hypertension, angina, and conditions involving excessive sympathetic nervous system activity.
Ertapenem Sodium
Ertapenem Dimer Impurity
Ertapenem N-Carbonyl Dimer Impurity
Ertapenem Oxazinone Impurity
Ertapenem Dimer I
Ertapenem Dimer II
N-Niroso Ertapenem Impurity
Ertapenemic Acid
Ertapenem Tautomer Dimer I
Ertapenem Pro MABA Impurity
Ertapenem Ring opened Impurity
Ertapenem Dimer III
